3rd ESO-ESSO Masterclass on Colorectal Cancer Surgery

Description

Chairs: T. Wiggers, NL - L. Påhlman, SE - P. Tekkis, UK

AIMS AND OBJECTIVES
Based on the knowledge of total mesocolon and total mesorectal surgey and imaging before the operation, after the Masterclass participants will be able to answer the 10 following questions:

• Is screening to be implemented?
• How does staging influence clinical decision making?
• Which information about genetics does influence treatment choices?
• Where do I damage the autonomic nerve plexus?
• How and when can I minimize the procedure?
• How do I position the patient for the perineal phase and perform a wide excision for low rectal cancers?
• How do I deal with the loss of a pelvic floor after a wide perineal resection and how do I correct a perineal hernia?
• How do I estimate the need of a defunctioning colostomy and how do I treat leakage of the anastomosis?
• How do I treat a patient with colorectal cancer and synchronous liver metastases?
• How do I balance the advantages and disadvantages of adjuvant treatment (numbers needed to treat)?

TEACHING FORMAT
The Masterclass offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines and which will conclude in take-home messages.
Workshop Sessions in small groups will be organised in areas of decision making in complex cases.
Furthermore, participants will deliver case presentations within small groups and discuss these with the chairmen and faculty.
All participants will reside at the course venue and participation is compulsory throughout the course.
The Masterclass will be entirely in English and fluency in English is necessary for admission.

THE MASTERCLASS IS:
• A 5-day residential educational event
• Full immersion
• Clinically-oriented
• Multidisciplinary
• An international faculty of top experts will contribute to the programme

General information

FOR INFORMATION PLEASE CONTACT:
Ana Galan, Education Coordinator
European Society of Surgical Oncology
Av. E. Mounier 83 - 1200 Brussels, Belgium
Ph. +32 2 7750243 - email: ana.galan@essoweb.org

ACCREDITATION
The Accreditation Council of Oncology in Europe (ACOE) and the European Accreditation Council for Continuing Medical Education (EACCME) have acknowledged the quality of the scientific programme and its educational value. The 3rd ESO-ESSO Masterclass in Colorectal Cancer Surgery has been assigned 27 European Continuing Medical Education Credits (ECMEC).
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org

.

Faculty list

FACULTY
G. Baatrup, Department of Surgery, Odense University Hospital, Odense, Institute of Regional Health Science, University of Southern Denmark, Odense, DK
G. Beets, Department of Surgery, Academic Hospital Maastricht, Maastricht, NL
K. Bujko, Department of Radiotherapy, Maria Slodowska-Curie Memorial Cancer Center, Warsaw, PL
M. de Ruiter, Department of Anatomy and Embryology, Leiden University Medical Center, Leiden, NL
S. Evrard, The Digestive Tumours Unit, Institute Bergonié, Bordeaux, FR
T. Holm, Department of Surgery, Karolinska University Hospital, Stockholm, SE
M. Martens, Department of Radiology/Surgery, Maastricht University Medical Center, Maastricht, NL
B. Moran, Department of Surgery, Basingstoke and North Hampshire Hospital, Basingstoke, UK
M. Morino, Department of Digestive and Minimal invasive Surgery, Univerity of Torino School of Medicine, Turin, IT
L. Påhlman, Department of Surgical Sciences, Section of Surgery, University Hospital Uppsala, Uppsala, SE
P. Pfeiffer, Institute of Clinical Research Odense University Hospital, Odense, DK
W. Polkowski, Department of Surgical Oncology, Medical University of Lublin, Lublin, PL
A. Rasulov, Russian Cancer Research Center, Moscow, RU
N. Scott, Department of Histopathology St. James’s University Hospital, Leeds, UK
J. Sougklakos, Medical School, University of Creete, Heraklion, GR
S. Stelzner, Department of Colorectal Surgery, Proctology, Klinik fur Allgemein-und Viszeral Chirurgie, Dresden, DE
W. Tarnovski, Klinika Chiturgii Ogolnej, Warsaw, PL
P. Tekkis, Department of Surgery, St. Mary’s NHS Trust, The Royal Marsden Hospital, London, UK
E. Tiret, Centre for Digestive Surgery, Saint-Antoine Hospital, Paris, FR
T. Wiggers, Department of Surgery, University Medical Centre Groningen, Groningen, NL

Programme

7 March


		Arrival of participants
18:00		Registration
20:00		*Welcome drink and dinner*

8 March


8:30		Lecture The history of colorectal cancer surgery T. Wiggers, NL
9:00		Workshop sessions: the four groups of participants will rotate among the workshop sessions (each will last 50’)
		How to become a robotic surgeon P. Tekkis, UK Cadaver demonstration: compartments, spaces, nerves and the pelvic floor Surgical anatomy of the ascending and transverse colon S. Stelzner, DE Practicum reading MRI M. Martens, NL
10:40		*Coffee break*
11:10		Workshop sessions, continuation
12:50		Lunch
14:00		Symposium Factors influencing decision making Chair: P. Tekkis, UK
		Inflammatory bowel disease and cancer J. Souglakos, GR Prognostic and predictive factors N. Scott, UK Staging based on high-quality imaging M. Martens, NL
15:30		Lecture Genetic and epigenetic analysis of sporadic colon cancer: Decision and treatment J. Souglakos, GR
16:00		*Coffee break*
16:30		Group sessions Case presentations by the participants - Based on the clinical case submitted w ith the applications - Group 1 - Chair: W. Tarnovski, PL - Group 2 - Chair: L. Påhlman, SE - Group 3 - Chair: S. Stelzner, DE - Group 4 - Chair: T. Holm, SE
18:00		End of daily programme
19:00		*Dinner*

9 March


8:30		Lecture Pathology: CRM and regression after chemoradiation N. Scott, UK
9:00		Workshop sessions: participants will rotate among the workshop sessions (each will last 50’)
		Endoluminal ultrasound G. Baatrup, DK Positioning and technique of a wide perineal resection T. Holm, SE Filling pelvic cavity, reconstrunction pelvic floor and perineal hernia’s T. Wiggers, NL 3D Resections in the pelvic P. Tekkis, UK
10:40		*Coffee break*
11:10		Workshop sessions, continuation
12:50		*Lunch*
14:00		Symposium Is less possible? Chair: T. Holm, SE
		Indications for TEM (Early cancer and polyps) G. Baatrup, DK Laparoscopic resections M. Morino, IT Ultralow resections E. Tiret, FR
15:30		*Coffee break*
16:00		Lecture Quality of life after rectal cancer E. Tiret, FR
16:30		Group sessions MDT conference - Group 1 - Chair: E. Tiret, FR - Group 2 - Chair: G. Baatrup, DK - Group 3 - Chair: A. Rasulov, RU - Group 4 - Chair: M. Morino, IT
18:00		End of daily programme
19:00		Dinner

10 March


8:30		Lecture Fields, beams and schedules in radiation oncology K. Bujko, PL
9:00		Workshop Sessions: the four groups of participants will rotate among the workshop sessions (each will last 50’)
		Stapling techniques A. Rasulov, RU LARS score and treatment T. Wiggers, NL Early detection and treatment of leakage T. Holm, SE Stoma’s: Colostomy, ileostomy, timing of closure G. Beets, NL
10:40		*Coffee break*
11:10		Workshops sessions, continuation
12:50		*Lunch*
14:30		Symposium Quality and organisation of care Chair: A. Rasulov, RU
		Value of a multidisciplinary team B. Moran,UK Follow-up: Evidence and optimalisation T. Wiggers, NL The colorectal audit L. Påhlman, SE
15:30		*Coffee break*
16:00		Lecture Response after chemoradiation on imaging G. Beets, NL
16:30		Group sessions Case presentations by the participants Based on the clinical cases submitted with the applications - Group 1 - Chair: B. Moran, UK - Group 2 - Chair: K. Bujko, PL - Group 3 - Chair: W. Polkowski, PL - Group 4 - Chair: L. Påhlman, SE
18:00		End of daily programme
19:00		Dinner

11 March


8:30		Lecture Systematic review and meta-analyses T. Wiggers, NL
9:00		Lectures and clinical debate by the participants with comments of the experts Symposium Numbers needed to treat: Neoadjuvant radiation therapy Chair: P. Tekkis, UK
		Neoadjuvant radiotherapy is evidence based Selected participant Critical comments Selected participant Discussion with the experts P. Pfeiffer, DK - B. Moran, UK - K. Bujko, PL. - G. Beets, NL
10:30		*Coffee break*
11:00		Transanal total mesorectal excision A. Rasulov, RU
11:30		Lectures and clinical debate by the particpants with comments of the experts Symposium Numbers needed to harm: Adjuvant chemotherapy in rectal cancer Chair: P. Tekkis, UK
		Is not proven to be efficacious Selected participant Critical comments Selected participant
13:00		Lunch
14:00		Symposium Advanced cases Chair: L. Påhlman, SE
		HIPEC B. Moran, RU Advanced rectal cancer W. Polkowski, PL Liver surgery after neo-adjuvant chemotherapy S. Evrard, FR
15:30		Coffee break
16:00		Lecture Radical Mesocolon resections S. Stelzner, DE
16:30		Group sessions Case presentations by the participants Based on the clinical cases submitted with the applications Group 1 - Chair W. Polkowski, PL Group 2 - Chair: S. Evrard, FR Group 3 - Chair: L. Påhlman, SE Group 4 - Chair: P. Tekkis, UK
18:00		End of daily programme
19:00		*Dinner*

12 March


8:30		Lecture Chemotherapy including biologicals P. Pfeiffer, DK

9:00		Workshop Sessions Making a protocol - Group 1: Patients with primary colorectal cancer and distant metastases - Group 2: Patients with locally advanced rectal cancer - Group 3: Patients with advanced colon cancer - Group 4: Patients with a complete remission after chemoradiation
10:00		Plenary Session Making a protocol presentation of the protocols with comment of the experts Chair: P. Tekkis, UK
		- Group 1: Patients with primary colorectal cancer and distant metasteses Selected participant from Group 1
10:15		Discussion with the experts P. Pfeiffer, DK - S. Evrard, FR - K. Bujko, PL - S. Stelzner, DE
10:30		- Group 2: Patients with locally advanced rectal cancer Selected participant from Group 2
10:45		Discussion with the experts P. Pfeiffer, DK - S. Evrard, FR - K. Bujko, PL - S. Stelzner, DE
11:00		Coffee break
11:30		Plenary Session Making a protocol - presentation of the protocols with comment of the experts Chair: L. Påhlman, SE
11:30		- Group 3: Patients with advanced colon cancer Selected participant from Group 3
11:45		Discussion with the experts P. Pfeiffer, DK - S. Evrard, FR - K. Bujko, PL - S. Stelzner, DE
12:00		- Group 4: Patients with a complete remission after chemoradiation Selected participant from Group 4
12:15		Discussion with the experts P. Pfeiffer, DK - S. Evrard, FR - K. Bujko, PL - S. Stelzner, DE
12:30		Closing remarks
13:00		Departures